Evoke Wealth’s Nutrien NTR Stock Holding History

Evoke Wealth’s Portfolio NTR Stock Details NTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-55	Closed	-$5K	–	869
2022 Q3	$5K	Hold	55	–	–	﹤0.01%	884
2022 Q2	$4K	Hold	55	–	–	﹤0.01%	942
2022 Q1	$6K	Sell	55 -219	-80%	-$18.1K	﹤0.01%	868
2021 Q4	$21K	Buy	274 +219	+398%	+$15.3K	﹤0.01%	671
2021 Q3	$3K	Hold	55	–	–	﹤0.01%	956
2021 Q2	$3K	Hold	55	–	–	﹤0.01%	993
2021 Q1	$3K	Hold	55	–	–	﹤0.01%	964
2020 Q4	$3K	Hold	55	–	–	﹤0.01%	831
2020 Q3	$2K	Hold	55	–	–	﹤0.01%	856
2020 Q2	$2K	Hold	55	–	–	﹤0.01%	882
2020 Q1	$1.89K	Sell	55 -155	-74%	-$6.2K	﹤0.01%	811
2019 Q4	$10.2K	Buy	210 +19	+10%	+$918	﹤0.01%	738
2019 Q3	$9.6K	Buy	+191	New	+$9.75K	﹤0.01%	830

Other funds holding NTR

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Evoke Wealth's NTR Position: Q4 2022 in Review

Evoke Wealth sold out of Nutrien (NTR) in Q4 2022, closing a stake of 55 shares — an estimated $5K sold.

Evoke Wealth first reported a position in NTR in Q3 2019 and held it in 13 quarters. The position peaked at $21K in Q4 2021. 695 funds tracked by Wall St. Rank hold NTR as of Q4 2022.

Evoke Wealth reported no remaining Nutrien position as of Q4 2022 after selling out during the quarter.
Evoke Wealth sold 55 Nutrien shares in Q4 2022, an estimated $5K.
Evoke Wealth first reported a position in Nutrien in Q3 2019 and held it in 13 quarters.
Evoke Wealth's Nutrien position peaked at $21K in Q4 2021.
695 funds tracked by Wall St. Rank held Nutrien as of Q4 2022.

Based on Evoke Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.